Isofagomine-impurities | Pharmaffiliates

Isofagomine and its Impurities

The treatment failed a clinical trial and is no longer under development. It is an experimental therapy that was developed by Amicus Therapeutics to treat Gaucher disease.Reference standards of Isofagomine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for Isofagomine Impurities
PA 09 83000

Isofagomine - API

Isofagomine


  • Catalogue No.:PA 09 83000

  • CAS :

    169105-89-9

  • Molecular Formula : C6H13NO3

  • Molecular Weight : 147.17

PA 09 0831000

Benzyl 2,3-O-[(1S,2S)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-a-L-xylopyranoside

Benzyl 2,3-O-[(1S,2S)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-a-L-xylopyranoside


  • Catalogue No.:PA 09 0831000

  • CAS :

    1084896-38-7

  • Molecular Formula : C18H26O7

  • Molecular Weight : 354.4

PA 09 0831001

Benzyl 2,3-O-[(1S,2S)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-4-nitrobenzoyl-α-L-xylopyranoside

Benzyl 2,3-O-[(1S,2S)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-4-nitrobenzoyl-α-L-xylopyranoside


  • Catalogue No.:PA 09 0831001

  • CAS :

    1084896-42-3

  • Molecular Formula : C25H29NO10

  • Molecular Weight : 503.5

PA 09 0831002

(2S,3S,4aR,8R,8aR)-Octahydro-2,3-dimethoxy-2,3-dimethyl-1,4-dioxino[2,3-c]pyridine-8-methanol

(2S,3S,4aR,8R,8aR)-Octahydro-2,3-dimethoxy-2,3-dimethyl-1,4-dioxino[2,3-c]pyridine-8-methanol


  • Catalogue No.:PA 09 0831002

  • CAS :

    1084896-52-5

  • Molecular Formula : C12H23NO5

  • Molecular Weight : 261.32